Levosalbutamol
Back to searchMolecule Structure
Scientific Name
Levosalbutamol
Description of the Drug
Levosalbutamol is a beta-2 adrenergic receptor agonist used to treat COPD and asthma.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB13139
http://www.drugbank.ca/drugs/DB13139
Brand Name(s)
Not Available
Company Owner(s)
Cipla Ltd, Mylan Specialty Lp, Sun Pharmaceutical Industries Ltd, Luoxin Aurovitas Pharma Chengdu Co Ltd, Teva Parenteral Medicines Inc, The Ritedose Corp, Teva Pharmaceuticals Usa, Impax Laboratories Inc, Sunovion Pharmaceuticals Inc, Akorn Operating Co Llc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Beta-2 adrenergic receptor | SINGLE PROTEIN | AGONIST | CHEMBL210 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL4003 | |||
DrugBank | DB13139 | |||
PubChem: Thomson Pharma | 14798337 | |||
PubChem | 123600 | |||
Mcule | MCULE-7261473820 | |||
LINCS | LSM-5480 | |||
Nikkaji | J428.072E | |||
PDBe | 68H | |||
BindingDB | 50361247 | |||
EPA CompTox Dashboard | DTXSID80187964 | |||
DrugCentral | 1575 | |||
ChemicalBook | CB0275903 | |||
Guide to Pharmacology | 9816 | |||
rxnorm | LEVALBUTEROL TARTRATE | XOPENEX | LEVALBUTEROL HYDROCHLORIDE | LEVALBUTEROL |
KEGG Ligand | C11770 | |||
ChEBI | 8746 | |||
ZINC | ZINC000000007601 |